The effect of pentoxifylline on diabetic microalbuminuria

Phase 3

Recruiting

• Conditions: Albuminuria in patients with diabetes Mellitus type II.; Diabetes mellitus due to underlying condition with kidney complications; E08.2

• Registration Number: IRCT20190107042264N3
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Type II Diabetic Patients
Proteinuria more than 150mg/24hours
Microalbuminuria of more than 20 mg albumin excretion in 24 hour urine

Exclusion Criteria

Patients Suffering from Diabetic Retinopathy
Hypersensitivity to pentoxifylline
Pregnancy
Heart failure with Ejection fraction less than 35%
Any acute or febrile illness one month before induction to study
Use of spironolactone
Use of Warfarin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Albuminuria. Timepoint: before intervention, 12 weeks after intervention. Method of measurement: 24-hour urine collection.